Acdt

Quick links to important sections

Acdt

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acdt

Acdt is a trade name for a medicine containing the active ingredient Simethicone, a widely recognized antiflatulent agent used to provide symptomatic relief from excessive gas in the digestive tract. It is classified as a gastrointestinal agent and is typically available as an Over-the-counter (OTC) medicine, reflecting its common use for relief from bloating and pressure.


Quick Facts: Acdt (Simethicone)

Property Description
Active ingredient Simethicone (Activated Dimethicone)
Common form Oral Suspension, Drops, Chewable Tablets
Pharmacological class Anti-foaming agent, Surface-active substance
General purpose Symptomatic relief of gas, bloating, and flatulence
Origin Synthetic silicone-based polymer

What Type of Medicine is Acdt, and What is its Composition?

Acdt contains Simethicone, which is chemically defined as an activated dimethicone or a silicone-based polymer, establishing its synthetic compound origin. Simethicone is characterized by high tolerability and a physical mechanism of action. It is a single-ingredient product belonging to the pharmacological class of anti-foaming agents. A typical differentiating factor for Simethicone preparations like Acdt is their patient group focus, often formulated as drops specifically for infants and small children to aid in the expulsion of gas.


What Pharmacological Class Does Simethicone Belong to?

Simethicone belongs to the class of surface-active substances, functioning through a purely physical mechanism of effect as a defoaming agent. This mechanism involves decreasing the surface tension of gas bubbles trapped in the gut, which facilitates the merging of small gas bubbles into larger ones. Its rapid action is clinically recognized for providing quick relief from acute gas pressure. Crucially, Simethicone is an inert substance with a non-systemic action, meaning it is not absorbed into the bloodstream and exerts its effect entirely within the confines of the digestive system before being eliminated unchanged.


What General Purpose Does Acdt Serve, and What Forms is it Available In?

The general purpose of Acdt is to provide effective and rapid gas relief, helping to reduce the feelings of pressure, pain, and discomfort associated with flatulence and bloating. A typical neutral use scenario would be relief from excessive abdominal gas buildup after consuming gas-producing foods. To serve its diverse target audience including infants, children, and adults, Acdt is manufactured in various pharmaceutical preparations, or dosage form(s), such as oral suspension, emulsion, chewable tablets, capsules, and drops. This variety ensures convenient administration for relieving symptoms linked to excessive gas formation and also aids in preparing patients for certain diagnostic imaging procedures by minimizing gas interference.

Regulatory References

  1. Pharmacological studies
  2. Simethicone (Oral Route) Monograph

What side effects are possible with Acdt?

Possible Side Effects and Safety Information

The safety profile for Acdt, which contains the active ingredient Simethicone, is intrinsically linked to its non-systemic action. As a physiologically inert substance, Simethicone is not absorbed into the bloodstream, which restricts its potential for systemic adverse effects as documented in official regulatory labeling.


Adverse Reaction Scope

Adverse effects reported in regulatory sources are typically categorized as low-incidence, primarily concerning allergic responses to the formulation's components.

Classification Associated Reactions (Regulatory Categories)
Frequency Primarily Rare or Very Rare
System-Organ Classes Immune System Disorders, Skin and Subcutaneous Tissue Disorders
Serious Reactions Potential for Angioedema and Anaphylaxis (very rare)

Official labeling defines serious adverse reactions as rare manifestations of hypersensitivity, which may include swelling beneath the skin or a severe allergic response.


Safety Restrictions and Limitations

The most significant safety restrictions defined in official prescribing information relate to patient conditions and known allergies:

  • Hypersensitivity: The medicine is contraindicated for individuals with a known or suspected allergy to Simethicone or any of the product's excipients.
  • Mechanical Obstruction: It is also contraindicated in cases of known or suspected intestinal obstruction or gastrointestinal perforation.

Population-specific safety notes regarding dose adjustments for organ impairment (renal or hepatic) are generally absent, consistent with the drug's lack of systemic absorption.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Acdt (Simethicone) overdose is structured by its status as an inert, non-systemic anti-foaming agent. Because the active ingredient is not absorbed into the bloodstream, government authorities generally state that there is minimal risk for systemic toxicity and that no cases of systemic overdose have been reported.


Documented Overdose Profile

Domain Regulatory Statement
Systemic Manifestations None explicitly documented; the non-absorbed nature makes systemic effects unlikely.
Theoretical Risk High ingestion volume may lead to constipation, affecting the gastrointestinal tract.
Antidote No specific antidote is known for Simethicone overdose.

Official Emergency Action Requirements

Regulatory agencies mandate specific procedural steps following accidental overdose. Prompt medical attention is critical and must be sought immediately, even if the person does not notice any signs or symptoms. All individuals, including adults as well as children, must seek professional assistance and contact a Poison Control Center immediately.

Overdose management is typically symptomatic and supportive, including keeping the patient under observation and treating with fluids. These requirements underscore the need for urgent professional guidance regardless of the drug's low systemic risk.

Therapeutic Uses of Acdt

What Acdt Treats: Main Uses and Benefits

ACDT may be used to help ease the symptoms associated with a specific category of conditions. The main indications for this medication include, but are not limited to, addressing discomfort related to acute conditions, helping to mitigate symptoms linked to inflammatory diseases, and offering relief from the symptomatic pain of chronic disorders.

A potential benefit for patients is the ability to help ease disruptive symptoms, supporting more manageable daily activities.

The established uses and potential benefits of this medicine are scientifically supported. This information reflects therapeutic standards for established drug use.


Quick Fact: Symptom Relief in Certain Conditions

Eligibility and Restrictions for Use

Who can and cannot use Acdt?

The population eligibility for Acdt (Simethicone) is determined by its profile as a non-systemically absorbed medicine. This means the active ingredient is not taken up by the bloodstream, resulting in broad authorization across all age groups and eliminating restrictions based on chronic organ function.

Approved Populations Acdt is approved for use across the entire lifespan, including infants (often in drop formulations), children, adolescents, and older adults (geriatric). Regulatory documents confirm no specific dose adjustments or restrictions are necessary for patients with renal (kidney) or hepatic (liver) impairment.

Contraindications Use of Acdt is absolutely contraindicated in any individual with a known hypersensitivity or allergy to Simethicone or any other ingredient in the specific formulation. The medicine must also not be used in cases of known or suspected gastrointestinal perforation or intestinal obstruction.

Conditional Eligibility While generally permitted due to non-absorption, use during pregnancy or breastfeeding is classified as conditional. Official regulatory labeling mandates that a health professional must be consulted prior to use. Additionally, the medicine must be discontinued if gas symptoms persist or worsen during use.

What should I know about interactions with other medicines?

Acdt (Simethicone) exhibits a highly constrained interaction profile due to its unique pharmacology as a non-systemic agent. Because the active ingredient is not absorbed into the bloodstream and is chemically inert, official regulatory labels confirm the absence of documented pharmacokinetic interactions involving CYP enzymes or major drug transporters, as well as the absence of pharmacodynamic interactions with other medicines.

The only formally documented interaction is a localized, exposure-modifying effect based on physical adsorption within the gastrointestinal tract. Co-administration of Acdt with Levothyroxine (a thyroid hormone medication) may result in a decrease in the oral absorption of the Levothyroxine, potentially reducing its systemic exposure. This effect is considered clinically significant.

To manage this interaction, official regulatory labeling establishes a mandatory timing separation requirement: products containing Simethicone must be administered at least 4 hours apart from Levothyroxine. This restriction ensures the absorption of the co-administered medication remains stable. Furthermore, regulatory documents explicitly state that no known interactions are documented with food, alcohol, or specific herbal products.

Mechanism of Action

Local Modulation of Surface Tension within the Gut

Acdt's active ingredient, Simethicone, operates through a purely physical and non-systemic mechanism confined entirely to the gastrointestinal lumen. It acts as a surface-active agent by directly targeting the liquid-gas interface, reducing the surface tension of the fluid films surrounding small, entrapped gas bubbles. This initial physical modulation is essential for destabilizing the foam or froth stabilized by surface tension.


Physical Coalescence and Facilitated Gas Expulsion

The reduction in surface tension promotes the coalescence of countless small, persistent gas bubbles into fewer, much larger, and more mobile gas pockets. This change in gas dynamics creates large, free gas pockets that are more readily cleared through physiological processes such as eructation and flatus, which facilitates the elimination of intra-luminal gas. The process requires no systemic absorption, ensuring the effect is localized to the gastrointestinal lumen.

Dosage and Administration Information

How to Use Acdt (Simethicone): Official Administration Guidelines

Administration of Acdt, which contains the active ingredient Simethicone, is strictly by the oral route. The official instructions are designed to align use with the periods of typical gas production, focusing on providing symptomatic relief in a non-systemic manner, as the drug is not absorbed into the bloodstream.

Official Usage Protocol

The usage protocol is defined by established parameters for administration:

Feature Official Administration Guideline
Administration Route Exclusively oral (by mouth).
Dosing Schedule Doses are typically taken after meals and at bedtime.
Frequency As-needed (PRN), with a maximum of up to four times daily (QID).
Adult Dose Range Doses commonly range from 40 mg to 125 mg per dose.
Maximum Daily Dose Intake must not exceed 500 mg in a 24-hour period.

Preparation and Population Rules

Specific steps must be followed for certain pharmaceutical preparations and patient groups to ensure proper administration. The dosage is differentiated by age, with lower-range dosing established for infants and children using the oral drops or suspension form.

For liquid forms, the product must be shaken well prior to use, and the dose must be accurately measured using the calibrated dropper provided. If a dose is missed, the standard approach is to take the dose as soon as possible unless it is nearly time for the next scheduled dose, thereby avoiding the taking of double doses. These standardized administration steps define the procedural use of the medicine.

Recent Clinical Evidence

Acdt: Recent Clinical Evidence

Research for Acdt (Simethicone) is focused on two main areas: its use for general symptomatic relief and its role as an aid during medical procedures. The evidence is derived primarily from short-term Randomized Controlled Trials (RCTs) and systematic reviews.


Evidence for Symptomatic Relief of Gas and Bloating

Research for Acdt’s general use consists of short-term RCTs that studied adult patients experiencing abdominal discomfort, pressure, and general flatulence. Studies examined patient-reported outcomes describing perceived discomfort. Findings describe patterns where patient-reported discomfort scores were lower compared to the comparator in many trials. However, when researchers attempted to measure objective changes, such as actual gas volumes, data showed patterns of inconsistent findings across different research settings.


Research for Diagnostic and Procedural Use

Acdt was evaluated in research contexts involving medical procedures like colonoscopy. The studies measured the quality of mucosal visualization by endoscopists. The addition of the medicine to standard preparation was reported by many studies to be associated with higher scores on visualization quality scales, which means fewer air bubbles were present. Findings regarding whether this improvement translates into a statistically significant change in the overall detection of polyps or lesions were mixed across the total body of research.


Evidence Gaps and Uncertainties

Long-term outcomes of routine, continuous use are not fully established, as follow-up durations were limited in the core studies. For specific groups, such as infants with colic, evidence is limited and often shows no notable difference in outcomes compared to a placebo. Certainty remains low regarding the contribution of Acdt as a single agent in the management of Functional Gastrointestinal Disorders (FGIDs), as positive observations often appear to be present when the medicine is studied within combination products.

Key Studies & References Simethicone Drug Label and Information

Frequently Asked Questions (FAQ)

Common questions about Acdt (FAQ)

Q: Is Acdt the same kind of medicine as [similar drug name]?

A: Official regulatory documents classify Acdt's active ingredient, Simethicone, as an antiflatulent agent. It belongs to the surface-active substances class, meaning its effect is strictly physical. This is a key distinguishing factor, as it acts only locally in the gut and is not absorbed into the bloodstream.

Q: Does Acdt interact with common cold medicines?

A: According to the official product information, there are no known pharmacokinetic or pharmacodynamic interactions with other medicines. The exception is a specific requirement for separating the timing of administration between Acdt and the thyroid medicine Levothyroxine. Therefore, based on its inert nature and limited documented interactions, Acdt maintains a low interaction profile.

Q: What are the possible interactions between Acdt and common pain relievers?

A: Regulatory documents indicate that Acdt (Simethicone) has a limited interaction profile because it is not absorbed into the body. Official sources state there are no known pharmacokinetic interactions with other medicines. This profile indicates a minimal risk of interaction with common pain relievers, aside from the specific timing separation required for Levothyroxine.

Q: What is the difference between Acdt and other older treatments for the same condition?

A: The key difference described in official sources is Acdt's mechanism of action. It is purely physical and non-systemic, acting locally to reduce the surface tension of gas bubbles in the gut. This promotes the merging and expulsion of gas. This non-systemic approach is a key pharmacological distinguishing factor.

Q: Can I take Acdt with multivitamins or herbal supplements?

A: Regulatory documents state that patients taking multivitamins, supplements, or herbal products should discuss them with a health professional prior to using Acdt. While Acdt's non-systemic nature limits traditional drug interactions, this consultation is generally recommended to ensure appropriate use with all other health products.

Q: What happens if I miss a scheduled amount of Acdt?

A: Official administration guidance is that if a dose is missed, you should take the dose as soon as possible. However, if it is nearly time for the next scheduled amount, regulatory documents instruct the user to skip the missed amount entirely. The guideline emphasizes avoiding the taking of double doses.

Q: How long after stopping Acdt does it take for the substance to clear the body?

A: Because Acdt is a non-systemic agent, its active ingredient is not absorbed into the bloodstream. Official information states it is eliminated unchanged via the feces shortly after passing through the digestive system. Therefore, a prolonged systemic presence of the substance is not a concern, given its non-absorbed profile.

Q: Does Acdt cause weight changes?

A: Official regulatory documents listing the reported adverse effects for Acdt do not document weight changes or metabolic side effects. The reported adverse effects are primarily rare immune system and skin disorders, which is consistent with the drug's lack of systemic absorption.

Q: Do studies suggest Acdt is taken short-term or long-term?

A: Research evidence is derived primarily from short-term Randomized Controlled Trials (RCTs). Regulatory warnings state that the medicine is typically not recommended for continuous use for more than two weeks unless its continued use is specifically directed by a health professional.

Q: How quickly does Acdt start working?

A: Official sources describe Acdt's action as rapid due to its physical mechanism of reducing gas bubble surface tension in the gut. This quick physical action is clinically recognized for providing quick relief from acute gas pressure and discomfort.

Q: Is it common to feel tired when first starting Acdt?

A: Official regulatory documents listing the adverse effects for Acdt do not include tiredness, drowsiness, or any other central nervous system (CNS) effects. This is consistent with the drug's inert nature and its confirmed lack of systemic absorption into the body.

Q: Can Acdt cause any long-term health problems?

A: The non-systemic mechanism suggests a low potential for long-term systemic health effects. However, official information notes that long-term outcomes of routine, continuous use are not fully established in clinical studies.

Q: What is the difference between Acdt and a placebo in studies?

A: Studies have described patterns where patient-reported discomfort scores were lower when using Acdt compared to a placebo in many trials. Conversely, when researchers tried to measure objective changes, such as actual gas volumes, the data often showed inconsistent findings compared to a placebo.

Q: Can Acdt affect my ability to drive or operate machinery?

A: Because Acdt is a non-systemic agent that is not absorbed into the bloodstream, official regulatory documents do not commonly include warnings regarding the impairment of the ability to drive or operate machinery.

Q: Is Acdt available as a generic medicine?

A: Yes, the active ingredient in Acdt, Simethicone, is the generic name for the medicine. As a widely recognized antiflatulent, the ingredient is broadly available in many over-the-counter (OTC) generic formulations.

Q: What happens if a minor side effect from Acdt bothers me?

A: Regulatory documents advise that if gas symptoms continue or if an adverse effect is bothersome, use of the product should be stopped. Official guidance is to consult with a health professional.

Q: Can I crush or split Acdt tablets?

A: Official administration protocol is highly specific and depends on the formulation. Users must swallow regular tablets or capsules whole and are instructed to thoroughly chew chewable tablets before swallowing. The product should be used exactly as directed on the label for its specific pharmaceutical preparation.

Q: What is the average length of time people take Acdt?

A: Regulatory warnings state that the medicine should not be taken for more than two weeks unless its continued use has been specifically directed by a health professional. This is consistent with its use for symptomatic relief of acute gas symptoms.

Q: What is the risk of dependence or withdrawal with Acdt?

A: Regulatory documents do not contain information regarding dependence or withdrawal risk. This absence is consistent with the medicine's classification as a non-systemic, inert agent that is not absorbed and does not produce systemic effects on the body or central nervous system.

Q: Does Acdt carry a Black Box Warning from regulatory agencies?

A: The official labeling for Acdt (Simethicone) does not carry a Black Box Warning from regulatory agencies. This warning is reserved for medicines with serious, potentially life-threatening risks.

Q: How does the effectiveness of Acdt compare across different age groups?

A: While Acdt is approved for use across all age groups, research findings regarding effectiveness have been inconsistent across the entire population. Official studies have shown no notable difference in outcomes compared to a placebo for infants with colic, though it is widely used in this group.

Q: Are there common mental or mood side effects associated with Acdt?

A: Official regulatory documents listing adverse effects do not document mental or mood side effects for Acdt. This lack of reported effects on the central nervous system is consistent with the drug's lack of systemic absorption into the body.

Q: Are there any warnings about combining Acdt with caffeine?

A: Official interaction documentation reports no known interaction between Acdt (Simethicone) and caffeine. The drug is classified as inert and non-systemic, leading to a minimal risk of interaction with foods or beverages.

Q: Does Acdt affect blood pressure?

A: Regulatory documents do not document an effect on blood pressure or the cardiovascular system. This is consistent with the drug's purely physical, non-systemic mechanism of action, meaning it does not enter the bloodstream to exert effects on major organs.

Q: Is Acdt generally considered a 'new' medicine?

A: No, the active ingredient in Acdt, Simethicone, is not considered a new medicine. Official history indicates that its active ingredient was first granted regulatory approval in the 1950s.

Q: What is the chance of experiencing a rare side effect from Acdt?

A: Official adverse reaction documents classify the reported immune and skin side effects for Acdt as primarily Rare or Very Rare. While a precise percentage is not provided, these categories indicate a low incidence of these specific adverse events.

Q: Why are there different strengths of Acdt available?

A: Different strengths and formulations, such as drops and chewable tablets, are available to facilitate accurate administration across various age groups. Official guidance notes that dosage is differentiated by age, with lower doses intended for infants and children.

Q: Are there specific food types that are known to interfere with Acdt?

A: Regulatory documents explicitly state that no known interactions are documented between Acdt and specific food types. The physical, non-systemic action of the drug makes it unlikely to be affected by the chemical components of most foods.

Q: What are the considerations for older adults using Acdt?

A: Acdt is approved for use across the entire lifespan, including the older adult (geriatric) population. Official regulatory documents contain no specific dose adjustments or restrictions for this group, consistent with the drug's lack of systemic absorption.

How should Acdt be stored and disposed of?

Official Storage Conditions

ACDT (Simethicone) must be stored at Controlled Room Temperature, which is typically defined as between 15 C and 30 C (59 F and 86 F). The product must be protected from excessive heat and moisture and should not be frozen. The liquid suspension forms must be kept in a light-resistant and tightly closed container. To prevent accidental ingestion, this medication must always be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired ACDT should be disposed of via a medicine take-back program. If a program is unavailable, the product must be mixed with an unappealing substance (such as dirt or coffee grounds), sealed in a bag, and then discarded with household trash. Do not flush this medication down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Acdt found in:

A-Z Index: